German-based leading biotechnology company c-LEcta, together with an unnamed leading ingredient supplier, have developed a new method to help expand production of a new stevia-based sweetener. The plant-based origin and safety of these sweeteners in combination with their very sugar-like taste make them suitable for large-scale use in low- and zero-calorie beverages and foods like diet products.

The process is based on the enzymatic treatment of precursors of these sweeteners. This new enzymatic treatment now makes it possible to convert the precursors into a better tasting sweetener efficiently. These sweeteners are safe and suitable for people with diabetes. The cultivation is more sustainable due to the smaller use of resources required in the process.

c-LEcta CEO Dr Marc Struhalla says: “The enzyme technology has the potential to enable our partner to change the world market for natural sweeteners decisively.”